ONCOLOGY remembers Dr Franco Muggia's contribution to cancer care.
Mike Hennessy Sr
Advertisement
Articles by Mike Hennessy Sr
B-cell maturation antigen target shows promise for patients with relapsed/refractory multiple myeloma.
The Chairman and founder of MJH Life Sciences discusses the current issue of ONCOLOGY®,
While the development of immunotherapy and targeted agents has advanced treatment options for a variety of malignancies, there is still the reminder that not all regimens work in treating cancer.
Advertisement
Latest Updated Articles
Finding The TargetAugust 12th 2020
ONCOLOGY Remembers Dr Franco MuggiaOctober 14th 2021
Forging Ahead in the COVID-19 eraJuly 15th 2020
Ensuring Decisional CapacityJune 16th 2020
Optimizing Therapies For Patients With Lung CancerDecember 7th 2020
Choosing the Right PathSeptember 22nd 2020
Advertisement
Advertisement
Trending on CancerNetwork
1
Frontline Sunvozertinib Improves PFS vs Chemotherapy in EGFR+ NSCLC
2
FDA Clears Investigator-Initiated IND for SRN-101 in Recurrent High-Grade Glioma
3
The Evolution of Artificial Intelligence in Oncology: Impact on Trials, Workflows, and Outcomes
4
Considering Venlafaxine as Distress Treatment in Breast Cancer
5